Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Intraarticular Corticosteroid Injections of the Temporomandibular Joint in Juvenile Idiopathic Arthritis

SARAH RINGOLD, TROY R. TORGERSON, MARK A. EGBERT and CAROL A. WALLACE
The Journal of Rheumatology June 2008, 35 (6) 1157-1164;
SARAH RINGOLD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TROY R. TORGERSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARK A. EGBERT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROL A. WALLACE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cwallace@u.washington.edu
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective

To describe the clinical and radiographic outcomes in a series of patients with juvenile idiopathic arthritis (JIA) who underwent one or more intraarticular corticosteroid (IAS) injections of the temporomandibular joint (TMJ) performed without imaging guidance.

Methods

Retrospective chart review was performed for all patients with JIA diagnosed and treated at our institution between January 1, 2000, and January 1, 2006, who underwent one or more IAS injections of their TMJ. IAS injections were performed by the same oral and maxillofacial surgeon without imaging guidance, using either triamcinolone acetonide or triamcinolone hexacetonide. The primary outcomes assessed were maximal incisal opening (MIO) measurements, patient-reported symptoms, physical examination findings, and imaging results.

Results

Twenty-five patients were identified. Twenty-one (84%) had radiographic evidence of TMJ disease when TMJ disease was first suspected by their physician. The 25 patients underwent 74 IAS injections on 47 separate occasions. When baseline MIO measurements were compared to the last MIO measurements of the study period, there was a mean increase in MIO of 6.9 mm (p = 0.002; 95% CI 3, 10.7). There was a mean increase in MIO of 3.8 mm following each IAS injection (p = 0.003; 95% CI 1.4, 6.2). Patients who underwent multiple IAS injections had a mean increase in MIO after first injection of 6.6 mm (p < 0.001; 95% CI 4.1, 9.1); however, the mean increase in MIO after subsequent injections was 0.4 mm (p = 0.8; 95% CI −3.5, 4.4). One patient developed subcutaneous atrophy at the injection site. Two patients developed small, asymptomatic intraarticular calcifications. No additional adverse events were reported.

Conclusion

In this patient population, there was an overall increase in MIO measurements following initial IAS injection and during the study period. Patients tended to have minimal response to subsequent injections. IAS injections performed without imaging guidance by an experienced oral and maxillofacial surgeon were well tolerated with only rare adverse events. The presence of radiographic changes when the physician first suspected TMJ disease in 84% of patients emphasizes the need for better screening and early intervention for synovitis in this joint.

Key Indexing Terms:
  • JUVENILE IDIOPATHIC ARTHRITIS
  • TEMPOROMANDIBULAR JOINT ARTHRITIS
  • INTRAARTICULAR CORTICOSTEROID INJECTIONS

Footnotes

  • S. Ringold, MD, Fellow; T.R. Torgerson, MD, PhD, Assistant Professor of Pediatrics, Division of Immunology, Rheumatology and Infectious Disease, Department of Pediatrics, University of Washington and Children’s Hospital and Regional Medical Center; M.A. Egbert, DDS, Associate Professor, Chief, Division of Pediatric Oral and Maxillofacial Surgery, Department of Pediatric Dental Medicine, Children’s Hospital and Regional Medical Center; C.A. Wallace, MD, Associate Professor of Pediatrics, Division of Immunology, Rheumatology and Infectious Disease, Department of Pediatrics, University of Washington and Children’s Hospital and Regional Medical Center; Vice Chair, Childhood Arthritis and Rheumatology Research Alliance (CARRA); Advisory Council, Pediatric Rheumatology Collaborative Study Group (PRCSG), Children’s Hospital and Regional Medical Center, Seattle, WA.

  • Supported by The Axtell-Steffes Foundation.

    • Accepted for publication January 28, 2008.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 35, Issue 6
1 Jun 2008
  • Table of Contents
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intraarticular Corticosteroid Injections of the Temporomandibular Joint in Juvenile Idiopathic Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Intraarticular Corticosteroid Injections of the Temporomandibular Joint in Juvenile Idiopathic Arthritis
SARAH RINGOLD, TROY R. TORGERSON, MARK A. EGBERT, CAROL A. WALLACE
The Journal of Rheumatology Jun 2008, 35 (6) 1157-1164;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Intraarticular Corticosteroid Injections of the Temporomandibular Joint in Juvenile Idiopathic Arthritis
SARAH RINGOLD, TROY R. TORGERSON, MARK A. EGBERT, CAROL A. WALLACE
The Journal of Rheumatology Jun 2008, 35 (6) 1157-1164;
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes
  • Canadian Rheumatology Association Annual Scientific Meeting TELUS Convention Centre Calgary, Alberta, Canada February 26–March 1, 2025
  • Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire